Cullinan Therapeutics, Inc. (CGEM)
NASDAQ: CGEM · Real-Time Price · USD
8.18
-0.15 (-1.80%)
At close: Jul 25, 2025, 4:00 PM
8.15
-0.03 (-0.37%)
After-hours: Jul 25, 2025, 6:01 PM EDT
Cullinan Therapeutics Market Cap
Cullinan Therapeutics has a market cap or net worth of $482.74 million as of July 25, 2025. Its market cap has decreased by -47.75% in one year.
Market Cap
482.74M
Enterprise Value
180.75M
1-Year Change
-47.75%
Ranking
Category
Stock Price
$8.18
Market Cap Chart
Since the IPO on January 8, 2021, Cullinan Therapeutics's market cap has decreased from $829.45M to $482.74M, a decrease of -41.80%. That is a compound annual growth rate of -11.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2025 | 482.74M | -31.93% |
| Dec 31, 2024 | 709.21M | 62.69% |
| Dec 29, 2023 | 435.93M | -9.73% |
| Dec 30, 2022 | 482.90M | -28.36% |
| Dec 31, 2021 | 674.05M | -18.74% |
| Jan 8, 2021 | 829.45M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 729.58B |
| Johnson & Johnson | 405.32B |
| AbbVie | 336.11B |
| Novo Nordisk | 315.59B |
| UnitedHealth Group | 254.96B |
| Novartis AG | 225.74B |
| AstraZeneca | 225.08B |
| Abbott Laboratories | 220.16B |